<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rentrad</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник рентгенологии и радиологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of radiology and nuclear medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4676</issn><issn pub-type="epub">2619-0478</issn><publisher><publisher-name>Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20862/0042-4676-2020-101-1-30-38</article-id><article-id custom-type="elpub" pub-id-type="custom">rentrad-530</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Результаты количественной оценки постлучевых изменений в легких у онкологических пациентов, полученные с помощью новой методики анализа динамически выполненных РКТ – исследований органов грудной клетки</article-title><trans-title-group xml:lang="en"><trans-title>The results of quantitative evaluation of postradiation changes in lung cancer patients, which were obtained using a new procedure for analysis of dynamic X-ray computed tomography imaging of thoracic organs</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2856-2107</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леденев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ledenev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Леденев Василий Владимирович, врач</p><p>ул. Щукинская, 20, Москва, 123182</p></bio><bio xml:lang="en"><p>Vasiliy V. Ledenev, doctor</p><p>ul. Schukinskaya, 20, Moscow, 123182</p></bio><email xlink:type="simple">LedenevVV007@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5994-0468</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нуднов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nudnov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нуднов Николай Васильевич, доктор медицинских наук, профессор, заместитель главного врача</p><p>ул. Профсоюзная, 86, Москва, 117997</p></bio><bio xml:lang="en"><p>Nikolay V. Nudnov, Dr. Med. Sc., Professor, Deputy Chief Physician</p><p>ul. Profsoyuznaya, 86, Moscow, 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сотников</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sotnikov</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сотников Владимир Михайлович, доктор медицинских наук, профессор, заведующий отделом</p><p>ул. Профсоюзная, 86, Москва, 117997</p></bio><bio xml:lang="en"><p>Vladimir M. Sotnikov, Dr. Med. Sc., Professor, Head of Department</p><p>ul. Profsoyuznaya, 86, Moscow, 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3086-6062</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барышникова</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Baryshnikova</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барышникова Дарья Владимировна, кандидат медицинских наук, заведующая отделением</p><p>ул. Профсоюзная, 86, Москва, 117997</p></bio><bio xml:lang="en"><p>Daria V. Baryshnikova, Cand. Med. Sc., Head of Department</p><p>ul. Profsoyuznaya, 86, Moscow, 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГКУ «Центральный Клинический Военный Госпиталь»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Clinical Military Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Российский научный центр рентгенорадиологии» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Scientific Center of Roentgenoradiology, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>03</month><year>2020</year></pub-date><volume>101</volume><issue>1</issue><fpage>30</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Леденев В.В., Нуднов Н.В., Сотников В.М., Барышникова Д.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Леденев В.В., Нуднов Н.В., Сотников В.М., Барышникова Д.В.</copyright-holder><copyright-holder xml:lang="en">Ledenev V.V., Nudnov N.V., Sotnikov V.M., Baryshnikova D.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.russianradiology.ru/jour/article/view/530">https://www.russianradiology.ru/jour/article/view/530</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. С помощью новой методики количественной оценки изменений плотности легочной ткани по данным динамического РКТ, выявить наличие зависимости изменений в легких от времени после лучевой терапии (ЛТ), дозы и объема облученной легочной ткани.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Ретроспективно были отобраны данные 29 онкологических пациентов, получавших ЛТ на область грудной клетки с использованием 3D-планирования, фракциями 2-5Гр и суммарной очаговой дозой в легочной ткани от 16Гр до 84 Гр. У каждого пациента имелось минимум два РКТ исследования (до и после ЛТ), всего было проанализировано 83 исследования. При помощью разработанной нами новой диагностической методики проводился количественный анализ изменения плотности легочной ткани в областях с выбранным диапазоном доз.</p></sec><sec><title>Результаты</title><p>Результаты. С 1 по 15-30 сутки после окончания ЛТ при количественном анализе достоверных изменений плотности не определяется. С 30 по 70-80 сутки – происходит нарастание изменений, отличных от необлученных участков. С 80 по 100-120 сутки – спад лучевой реакции с сохранением изменений в зонах, облученных в дозе от 19-20Гр. С 120 суток и далее – сохраняются изменения в зонах, облученных в дозе более 32-37Гр, за счет формирования постлучевого пневмофиброза. Помимо этого у 8 (27,6%) пациентов были выявлены изменения при дозе менее 20Гр, связанные с исходными значениями плотности, что может быть расценено как повышенная индивидуальная радиочувствительность.</p></sec><sec><title>Выводы</title><p>Выводы. Динамика количественного изменения медианы плотности легочной ткани в участках легкого, облученных в различных дозах, позволяет выявить при РКТ радиационное повреждение легкого до появления визуальных признаков пульмонита. Непрерывная, количественная шкала изменений поможет в дальнейшем более надежно и точно исследовать постлучевые изменения, а временно-пространственная динамика изменений позволит сравнивать и количественно оценивать повреждения легких при исследовании новых способов и тактик лечения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to reveal a relationship of lung changes to time after radiotherapy (RT), its dose, and irradiated volume, by using a new procedure to quantitatively evaluate lung tissue density changes according to the data of dynamic X-ray computed tomography (X-ray CT) imaging.</p></sec><sec><title>Subjects and methods</title><p>Subjects and methods. Data on 29 cancer patients who had received RT to the chest area using 3D planning, 2-5-Gy fractions, and a total focal RT dose of 16 to 84 Gy in the lung tissue were retrospectively selected. Each patient underwent at least two X-ray CT studies (before and after RT); a total of 83 studies were analyzed. The new diagnostic procedure developed by the authors was used to quantitatively analyze lung tissue density changes in the areas with a selected dose range.</p></sec><sec><title>Results</title><p>Results. On days 1 to 15-30 after completion of RT, the quantitative analysis revealed no significant density changes. On days 70-80, there was an increase in changes that were different from those in the nonirradiated areas. On 80 to 100-120 days, there was a decline of radiation reactions with preserved changes in the areas irradiated at a dose of 19-20 Gy. From 120 days onwards, the changes were preserved in the areas irradiated at a dose of over 32-37 Gy through the formation of post-radiation pulmonary fibrosis. In addition, eight (27.6%) patients treated with less than 20 Gy were detected to have changes associated with the initial density values, which can be regarded as an increased individual radiosensitivity.</p></sec><sec><title>Conclusion</title><p>Conclusion. The time course of a quantitative change in the median lung tissue density in the areas irradiated at different doses allows radiation-induced lung injury to be detected at X-ray CT until the visual signs of pneumonitis appear. A continuous, quantitative scale of changes will assist in more reliably and accurately studying post-radiation changes at a later time, and the time course of spaciotemporal changes will be able to compare and quantify lung injury when exploring new treatment methods and policies.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>лучевые повреждения легких</kwd><kwd>индивидуальная радиочувстивительность</kwd><kwd>лучевая терапия</kwd><kwd>рентгеновская компьютерная томография</kwd><kwd>количественная оценка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>radiation-induced lung injury</kwd><kwd>individual radiosensitivity</kwd><kwd>radiotherapy</kwd><kwd>X-ray computed tomography</kwd><kwd>quantitative evaluation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mackie TR. History of tomotherapy. Phys Med Biol. 2006 Jul 7;51(13):R427-53. DOI: 10.1088/0031-9155/51/13/R24.</mixed-citation><mixed-citation xml:lang="en">Mackie TR. History of tomotherapy. Phys Med Biol. 2006 Jul 7;51(13):R427-53. DOI: 10.1088/0031-9155/51/13/R24.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Grills IS, Hope AJ, Guckenberger M, Kestin LL, WernerWasik M, Yan D et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J ThoracOncol. 2012 Sep;7(9):1382-93. DOI: 10.1097/JTO.0b013e318260e00d.</mixed-citation><mixed-citation xml:lang="en">Grills IS, Hope AJ, Guckenberger M, Kestin LL, WernerWasik M, Yan D et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J ThoracOncol. 2012 Sep;7(9):1382-93. DOI: 10.1097/JTO.0b013e318260e00d.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. LancetOncol. 2012 Aug;13(8):8029. DOI: 10.1016/S1470-2045(12)70242-5.</mixed-citation><mixed-citation xml:lang="en">Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. LancetOncol. 2012 Aug;13(8):8029. DOI: 10.1016/S1470-2045(12)70242-5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Oskan F, Becker G, Bleif M. Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review. StrahlentherOnkol. 2017 Mar;193(3):173184. DOI: 10.1007/s00066-016-1063-z.</mixed-citation><mixed-citation xml:lang="en">Oskan F, Becker G, Bleif M. Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review. StrahlentherOnkol. 2017 Mar;193(3):173184. DOI: 10.1007/s00066-016-1063-z.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K et al. Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV_100cc. RadiotherOncol. 2017 Feb;122(2):281-285. DOI: 10.1016/j.radonc.2016.11.022.</mixed-citation><mixed-citation xml:lang="en">Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K et al. Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV_100cc. RadiotherOncol. 2017 Feb;122(2):281-285. DOI: 10.1016/j.radonc.2016.11.022.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R et al. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017 Nov16; 377(20):1919-1929. DOI: 10.1056/NEJMoa1709937.</mixed-citation><mixed-citation xml:lang="en">Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R et al. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017 Nov16; 377(20):1919-1929. DOI: 10.1056/NEJMoa1709937.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin. 2018 Mar;68(2):116-132. DOI: 10.3322/caac.21438.</mixed-citation><mixed-citation xml:lang="en">Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin. 2018 Mar;68(2):116-132. DOI: 10.3322/caac.21438.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS et al. Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy. J ThoracOncol. 2019 Mar;14(3):494-502. DOI: 10.1016/j.jtho.2018.11.016.</mixed-citation><mixed-citation xml:lang="en">Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS et al. Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy. J ThoracOncol. 2019 Mar;14(3):494-502. DOI: 10.1016/j.jtho.2018.11.016.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Нуднов Н.В., Сотников В.М., Леденев В.В., Барышникова Д.В. Возможности качественной оценки лучевых повреждений легких методом компьютерной томографии. Медицинская визуализация. 2016; (1): 39-46.</mixed-citation><mixed-citation xml:lang="en">Nudnov N.V., Sotnikov V.M., Ledenev V.V., Baryshnikova D.V. Features a Qualitative Assessment of Radiation-Induced Lung Damage by CT. Medical Visualization. 2016;(1):39-46. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Нуднов Н.В., Сотников В.М., Леденев В.В., Барышникова Д.В. Возможности количественной оценки лучевых повреждений легких методом компьютерной томографии. Медицинская визуализация. 2016; (3): 85-94.</mixed-citation><mixed-citation xml:lang="en">Nudnov N.V., Sotnikov V.M., Ledenev V.V., Baryshnikova D.V. Quantitative Estimation of Radiation-induced Lung Damage by CT. Medical Visualization. 2016;(3):85-94. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Defraene G, La Fontaine M, van Kranen S, Reymen B, Belderbos J, Sonke JJ et al. Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of DoseEscalation Level or Volume. Int J RadiatOncolBiol Phys. 2018 Nov1;102(3):642-650. DOI: 10.1016/j.ijrobp.2018.06.038.</mixed-citation><mixed-citation xml:lang="en">Defraene G, La Fontaine M, van Kranen S, Reymen B, Belderbos J, Sonke JJ et al. Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of DoseEscalation Level or Volume. Int J RadiatOncolBiol Phys. 2018 Nov1;102(3):642-650. DOI: 10.1016/j.ijrobp.2018.06.038.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ghobadi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S et al. Quantifying local radiation-induced lung damage from computed tomography. Int J RadiatOncolBiol Phys. 2010 Feb 1;76(2):548-56. DOI: 10.1016/j.ijrobp.2009.08.058.</mixed-citation><mixed-citation xml:lang="en">Ghobadi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S et al. Quantifying local radiation-induced lung damage from computed tomography. Int J RadiatOncolBiol Phys. 2010 Feb 1;76(2):548-56. DOI: 10.1016/j.ijrobp.2009.08.058.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ghobadi G, Wiegman EM, Langendijk JA, Widder J, Coppes RP, van Luijk P. A new CT-based method to quantify radiationinduced lung damage in patients. RadiotherOncol. 2015 Oct;117(1):4-8. DOI: 10.1016/j.radonc.2015.07.017.</mixed-citation><mixed-citation xml:lang="en">Ghobadi G, Wiegman EM, Langendijk JA, Widder J, Coppes RP, van Luijk P. A new CT-based method to quantify radiationinduced lung damage in patients. RadiotherOncol. 2015 Oct;117(1):4-8. DOI: 10.1016/j.radonc.2015.07.017.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Phernambucq EC, Palma DA, Vincent A, Smit EF, Senan S. Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer. Lung Cancer. 2011 Dec;74(3):451-6. DOI: 10.1016/j.lungcan.2011.05.010.</mixed-citation><mixed-citation xml:lang="en">Phernambucq EC, Palma DA, Vincent A, Smit EF, Senan S. Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer. Lung Cancer. 2011 Dec;74(3):451-6. DOI: 10.1016/j.lungcan.2011.05.010.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Defraene G, van Elmpt W, Crijns W, De Ruysscher D. Regional variability in radiation-induced lung damage can be predicted by baseline CT numbers. RadiotherOncol. 2017 Feb;122(2):300-306. DOI: 10.1016/j.radonc.2016.11.021.</mixed-citation><mixed-citation xml:lang="en">Defraene G, van Elmpt W, Crijns W, De Ruysscher D. Regional variability in radiation-induced lung damage can be predicted by baseline CT numbers. RadiotherOncol. 2017 Feb;122(2):300-306. DOI: 10.1016/j.radonc.2016.11.021.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Defraene G, van Elmpt W, Crijns W, Slagmolen P, De Ruysscher D. CT characteristics allow identification of patient-specific susceptibility for radiation-induced lung damage. RadiotherOncol. 2015 Oct;117(1):29-35. DOI: 10.1016/j.radonc.2015.07.033.</mixed-citation><mixed-citation xml:lang="en">Defraene G, van Elmpt W, Crijns W, Slagmolen P, De Ruysscher D. CT characteristics allow identification of patient-specific susceptibility for radiation-induced lung damage. RadiotherOncol. 2015 Oct;117(1):29-35. DOI: 10.1016/j.radonc.2015.07.033.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Distel LV, Neubauer S, Keller U, Sprung CN, Sauer R, Grabenbauer GG. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiother Oncol. 2006 Dec;81(3):257-63. DOI: 10.1016/j.radonc.2006.10.012.</mixed-citation><mixed-citation xml:lang="en">Distel LV, Neubauer S, Keller U, Sprung CN, Sauer R, Grabenbauer GG. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiother Oncol. 2006 Dec;81(3):257-63. DOI: 10.1016/j.radonc.2006.10.012.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Нуднов Н.В., Сотников В.М., Леденев В.В. Новая методика количественной оценки постлучевых изменений в легких у онкологических больных на основании данных динамической КТ. Медицинская визуализация. 2017; 5: 56-65. DOI: 10.24835/1607-0763-2017-5-56-65.</mixed-citation><mixed-citation xml:lang="en">Nudnov N.V., Sotnikov V.M., Ledenev V.V. A new Method of Quantitative Estimation of Radiation-Induced Lung Damage in Oncological Patients on the CT in Dynamics. Medical Visualization. 2017;(5):56-65. (In Russ.) https://doi.org/10.24835/1607-0763-2017-5-56-65.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
